shareman - before I give you the answer, I should express my view that the analysis is misleading. ASX life sciences coys were significantly overvalued for a while and a lot folks have been burnt. Biotron is not an exception to this general trend.
The reduction in price has been exacerbated by Michelle Miller's lack of ability to execute on what is a very strong underlying compound portfolio. She bet the house on HCV and she has lost..
BIT appears to have listed at 50c per share in 2000. I am not a founding shareholder and have found the information here: http://www.biotron.com.au/wp-content/uploads/2013/04/Biotron_assirt_review.pdf
Therefore, at current price of 6.5c per share, your hypothetical $100 will be worth $13
PS - nobody forced you to invest in BIT as you say. However, as a shareholder, you have the right to demand transparency
shareman - before I give you the answer, I should express my...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
